Abstract

BackgroundIt is difficult to predict lymph node metastasis in patients with early lung cancer. Pure ground glass opacity (GGO) on computed tomography indicates an early-stage adenocarcinoma that can be removed by limited resection or lobectomy without the need for mediastinal lymph node dissection or sampling, and lung adenocarcinoma with GGO therefore has a good prognosis. We examined the incidence and risk factors of lymph node metastasis in patients with clinical stage IA lung adenocarcinoma.MethodsWe retrospectively analyzed clinical data for 327 patients with stage IA peripheral lung cancer treated in our hospital from March 2014 to December 2018. The patients were divided into four groups according to computed tomography signs. Lobectomy and systematic lymph node dissection were performed in all patients. Correlations between lymph node metastasis and clinical pathological factors were analyzed by logistic regression.ResultsAmong the 327 patients, 26 (7.95%) had lymph node metastasis. No patients with pure GGO or GGO-dominant types had lymph node metastasis. Logistic regression identified tumor diameter, solid content, plasma carcinoembryonic antigen (CEA) level, pathological type, lymphovascular invasion, and pleural invasion as factors related to the presence of lymph node metastasis.ConclusionsTumor diameter, solid component ratio, plasma CEA level, pathological type, vascular tumor thrombus, and pleural invasion are possible independent risk factors for lymph node metastasis in patients with stage IA lung adenocarcinoma. In contrast, lymph node metastasis is rare in patients with pure GGO or GGO-dominant lung adenocarcinoma.

Highlights

  • It is difficult to predict lymph node metastasis in patients with early lung cancer

  • Twenty-six patients (7.95%) had mediastinal lymph node metastasis, including (3.1%) with only N1 lymph node metastasis, five (1.5%) with only skip N2 metastatic lymph nodes with no N1 positive nodes, and patients (3.4%) with both N1 and N2 lymph node metastasis

  • No mediastinal lymph node metastasis was present in the pure GGO (PGGO) and ground glass opacity (GGO) groups, while nine patients (9/120) with solid component dominant type and 17 (17/114) with pure solid tumor type had mediastinal lymph node metastasis

Read more

Summary

Introduction

It is difficult to predict lymph node metastasis in patients with early lung cancer. Pure ground glass opacity (GGO) on computed tomography indicates an early-stage adenocarcinoma that can be removed by limited resection or lobectomy without the need for mediastinal lymph node dissection or sampling, and lung adenocarcinoma with GGO has a good prognosis. We examined the incidence and risk factors of lymph node metastasis in patients with clinical stage IA lung adenocarcinoma. Progress in computed tomography (CT) has led to an increase in the detection rate of early lung nodules, including many early lung cancers [4], with relatively low malignancy and a good postoperative prognosis. We retrospectively examined the incidence and risk factors of lymph node metastasis in patients with clinical stage IA peripheral lung adenocarcinoma with GGO findings, with the aim of providing evidence for future clinical applications

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.